Edition:
India

PhaseRx Inc (PZRX.OQ)

PZRX.OQ on NASDAQ Stock Exchange Capital Market

0.64USD
22 Nov 2017
Change (% chg)

$0.00 (+0.17%)
Prev Close
$0.64
Open
$0.67
Day's High
$0.67
Day's Low
$0.64
Volume
2,401
Avg. Vol
58,145
52-wk High
$3.30
52-wk Low
$0.55

Select another date:

Thu, Nov 9 2017

BRIEF-PhaseRx reports Q3 loss per share $0.23

* PhaseRx reports third quarter 2017 financial results and provides corporate update

BRIEF-Phaserx gets delisting notice from NASDAQ

* Says receipt of delisting notice from NASDAQ informing trading in co's stock will be suspended from NASDAQ at opening of business on Nov 1​ Source text for Eikon: Further company coverage:

BRIEF-Phaserx announces corporate restructuring and review of strategic alternatives

* PhaseRx announces corporate restructuring and review of strategic alternatives

BRIEF-PhaseRx receives Orphan Drug Designation from FDA for PRX-ASL

* PhaseRx receives Orphan Drug Designation from FDA for PRX-ASL for the treatment of Argininosuccinate Lyase Deficiency Source text for Eikon: Further company coverage:

BRIEF-Phaserx reports Q2 loss per share $0.30

* Phaserx reports second quarter 2017 financial results and provides corporate update

BRIEF-PhaseRx files for stock and warrants offering of up to $15 mln

* PhaseRx Inc files for stock and warrants offering of up to $15 million - sec filing Source text: (http://bit.ly/2sBPItI) Further company coverage:

Select another date: